Payer comparison · HCPCS J3245 · EMMETT, ID

J3245 — Tildrakizumab-asmn 100 Mg/ml Subcutaneous Syringe

What each payer pays VALOR HEALTH (CCN 131318) for this procedure, and where each sits versus the all-payer median at this facility. Find your plan to see whether you're above or below the market here.

$33,902 All-payer median here

$37,041 Cash / self-pay here

14 payer/plan-name variants

← This hospital National rates for J3245 →

Per-payer negotiated rate at this facility. Use the column headers to sort, the filter row to narrow results.
Payer / plan	Median negotiated	vs all-payer median	Rate rows

Blue Shield of California	$38,406	13.3%	2
BLUE CROSS COMM - ALL OTHER PLANS	$38,211	12.7%	1
MODA HEALTH - ODS MEDICAL	$37,041	9.3%	1
SelectHealth	$37,041	9.3%	1
BLUE CROSS QHP	$36,300	7.1%	1
Cigna Healthcare	$35,618	5.1%	2
PacificSource	$29,116	-14.1%	2
Humana	$28,268	-16.6%	2
UnitedHealthcare	$27,176	-19.8%	2
Aetna	$25,441	-25.0%	2
Molina Healthcare	$18,326	-45.9%	1
Regence BCBS	$18,326	-45.9%	1
BLUE CROSS MCR ADV	$18,326	-45.9%	1
PGBA TRIWEST VA CCN	$17,776	-47.6%	1

Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.